Follicular growth and development under continuous gonadotropin-releasing hormone antagonist administration.
暂无分享,去创建一个
[1] E. Kolibianakis,et al. GnRH antagonists in ovarian stimulation for IVF. , 2006, Human reproduction update.
[2] M. Glezerman,et al. A Randomized Prospective Study Comparing the Use of a Standard GnRH Antagonist Versus a ‘Long’ Antagonist Protocol for Controlled Ovarian Hyperstimulation Prior to IVF , 2005 .
[3] M. Aboulghar,et al. GnRH antagonist in assisted reproduction: a Cochrane review. , 2002, Human reproduction.
[4] M. Almagor,et al. The development of an oocyte-containing follicle during gonadotrophin-releasing hormone agonist administration. , 2001, Human reproduction.
[5] O. Ortmann,et al. Embryo implantation and GnRH antagonists: ovarian actions of GnRH antagonists. , 2001, Human reproduction.
[6] R. Casper,et al. Ovarian hyperstimulation following the sole administration of agonistic analogues of gonadotrophin releasing hormone. , 1998, Human reproduction.
[7] Z. Shoham,et al. Prospective evaluation of endometrial thickness as a predictor of pituitary down-regulation after gonadotropin-releasing hormone analogue administration in an in vitro fertilization program. , 1998, Fertility and sterility.
[8] E. Thomas,et al. The development of functional ovarian cysts during pituitary down-regulation. , 1993, Human reproduction.